In the first stage of ROP, hyperoxia suppresses the production of vascular endothelial growth factor (VEGF) and erythropoietin (EPO), leading to retinal vasoconstriction and localized hypoxia, ultimately causing delayed retinal development. The gene discussed is VEGFA; the disease is retinopathy of prematurity.